Predicting suicidal ideation using multiple serum biomarkers in patients with acute coronary syndrome

Jae-Min Kim,Ju-Wan Kim,Hee-Ju Kang,Wonsuk Choi,Ju-Yeon Lee,Sung-Wan Kim,Il-Seon Shin,Youngkeun Ahn,Myung Ho Jeong
DOI: https://doi.org/10.1016/j.jad.2024.02.008
IF: 6.533
2024-02-16
Journal of Affective Disorders
Abstract:Background Biomarkers for suicidal behavior in patients with acute coronary syndrome (ACS) have yet to be elucidated. This study aimed to identify a panel of serum biomarkers associated with suicidal ideation (SI) in patients with ACS. Methods The study evaluated 969 patients within 2 weeks of ACS (acute phase) and 711 patients 12 months later (chronic phase). The evaluation included 14 serum biomarkers covering 7 functional systems, socio-demographic/clinical characteristics, and SI assessed by the "suicidal thoughts" item of the Montgomery–Åsberg Depression Rating Scale. Logistic regression models were used to analyze the data. The results showed that 195 patients (20.1 %) had SI in the acute phase, and 87 patients (12.2 %) had SI in the chronic phase. Results A combination of five serum biomarkers (tumor necrosis factor-α, interleukin-1β, folate, troponin I, and creatine kinase-MB) was significantly associated with SI in the acute phase, and a combination of three serum biomarkers (tumor necrosis factor-α, interleukin-1β, and folate) was significantly associated with SI in the chronic phase in a clear dose-dependent manner (all P-values < 0.001) after adjustment for relevant covariates. Discussion These findings suggest that the application of a combination of multiple serum biomarkers could improve the predictability of SI in patients with ACS at both acute and chronic phases.
psychiatry,clinical neurology
What problem does this paper attempt to address?